Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

f_44933

New UK research illuminates new developments for anticancer treatment

October 26, 2016 Research and Development anticancer

New research from the University of Huddersfield has shed light on a new lab technique which could aid in the …
News
stocks1

Colombian pharma market to break $7 billion by 2020

October 24, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Colombia, market report

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …
News

Phase III depression trial success for Alkermes

October 24, 2016 Research and Development, Sales and Marketing ALKS 5461, Alkermes, major depressive disorder

Biopharma company Alkermes has announced the success of its ALKS 5461 treatment in a Phase III study for the treatment …
News
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …
News
sunset-flag-america-fields

The Pharmafocus guide to the US presidential election 2016

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing US election, feature

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …
Feature
novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …
News
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …
News

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
News
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …
News
vaccine3a-062568e

Sun Pharma partners with ICGEB to develop dengue vaccine

October 19, 2016 Research and Development Vaccine, dengue, icgeb, sun pharmaceutical

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …
News
lilly_corporate_hq

Lilly announces plan to expand global access to health care

October 19, 2016 Research and Development Eli Lilly, Lilly 30x30, global health

Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …
News

Roche’s immunotherapy cancer drug given FDA approval

October 19, 2016 Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer

Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …
News

Recipharm to open largest Nordic GLP bioanalysis lab

October 19, 2016 Manufacturing and Production, Research and Development Recipharm, Sweden, expansion

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …
News
fdaoutsideweb

FDA grants $23 million to boost research on rare diseases

October 19, 2016 Research and Development Cancer, FDA, clinical trials, oncology

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …
News
shutterstock_138095450

Quark to set up “largest biotechnology fund in Canada” for $500m

October 18, 2016 Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund

Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025